Peter Libby - 22 Jun 2022 Form 4 Insider Report for XBiotech Inc. (XBIT)

Role: Director
Signature: /S/ Queena Han under Power of Attorney for Peter Libby
Issuer symbol: XBIT
Transactions as of: 22 Jun 2022
Transactions value $: $0
Form type: 4
Filing time: 27 Jun 2022, 17:54:18 UTC
Previous filing: 12 Jul 2021
Next filing: 26 Jun 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	XBIT	Director Stock option	Award	$0	+25,000		$0	25,000	22 Jun 2022	Common Stock	25,000	$5.89	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

On June 22, 2022 (the Grant Date) the reporting person was granted nonstatutory stock options (the Options) under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market. The Options vest in two equal portions at six month and one year from the Grant Date with an expiry of ten years from the Grant Date.